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Aims: To analyze the correlation between neck circumference (NC) and non-alcoholic fatty liver disease
(NAFLD) and compare the predictive value of NC for NAFLD with that of other simple anthropometric
measures and other biochemical proﬁles.
Methods: 2761 subjects, undergoing a medical check-up at the Changhai Hospital between October 01,
2012 and November 30, 2012, were recruited to the study. NC, other simple anthropometric measures,
and biochemical proﬁles were analyzed.
Results: NC in NAFLD subjects with or without elevated ALT were 38.94  2.62 cm and 37.21  3.06 cm
respectively, which was signiﬁcantly higher than that in subjects with other metabolic disorders (NC:
35.33  3.03 cm) and in normal controls (NC: 32.60  2.37) (both P < 0.001). NC in women with NAFLD
increased by 1 cm and fasting insulin (FINS) and homeostasis model assessment-insulin resistance
(HOMA-IR) increased by 1.87 mIU/L and 1.43, respectively. Compared with other anthropometric mea-
sures, neck circumference-height ratio (NHtR) had a signiﬁcant impact both on the incidence of NAFLD.
After adjustment for sex, abdominal obesity and other inﬂuencing factors, the incidence of NAFLD still
tended to positively correlate with NC. Optimal cut-off points of NC and NHtR for predicting NAFLD in
males were 37.25 cm and 0.224, respectively, and such points in females were 32.90 cm and 0.208,
respectively.
Conclusion: NC was wider in NAFLD patients than in healthy subjects and other metabolic disorder
sufferers. NC and NHtR could be used as simple predictive tools for NAFLD.
 2014 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.onalcoholic fatty liver disease; NHtR, Neck circumference-height ratio; T2DM, Type 2 diabetes mellitus; IR, Insulin
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cid; BUN, Blood urea nitrogen; Scr, Serum creatinine; HbA1c, Hemoglobin A1c; FINS, Fasting insulin; FT3, Free triio-
ulating hormone; QUICKI, Quantitative insulin-sensitivity check index; AUC, Area under the curve; OR, Odd ratio.
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collected and assayed for a series of metabolic parameters includingSimilar to type 2 diabetes mellitus (T2DM), non-alcoholic fatty
liver disease (NAFLD) is becoming aworldwide epidemic and one of
themost important global public health issues [1,2]. It is a challenge
for both eastern andwestern countries in the 21st century. NAFLD is
a kind of metabolic hepatic injury that is closely related to insulin
resistance (IR) and hereditary susceptibility. It had been recognized
as both a liver manifestation and a major component of metabolic
syndrome (MS); however, an increasing number of prospective
studies indicate that NAFLD could be a predictor of T2DM, inde-
pendent of obesity [3]. It is also an independent predictor of car-
diovascular diseases (CVD) [4,5].
Although the exact pathogenesis of NAFLD and its causality with
IR and MS have not been elucidated, it is indicated by both in vivo
and in vitro studies that excess fat accumulation mainly in the form
of triglyceride (TG) is the prerequisite for NAFLD, and could there-
fore be the root of MS. At present, the diagnosis of NAFLD is made by
liver biopsy, known as “the golden standard,” or by MRI/CT scan.
These methods are either invasive or costly, and therefore are not
suitable for routine clinical practice. Furthermore, most early-stage
NAFLD patients are virtually asymptomatic. They are diagnosed
during medical checkups or ultrasound and CT tests due to other
reasons. Most of NAFLD subjects are often complicated with other
metabolic disturbances, including dysglycemia at diagnosis.
Therefore, if simple and convenient methods like anthropometric
measures could be established, early stage NAFLD could be detected
and treated effectively, which ultimately could prevent or delay the
onset and development of T2DM.
Neck circumference (NC) is the girth of the neck measured at a
point just below the laryngeal prominence. It is easy to measure
with excellent repeatability and minimal variance. NC is an
important index reﬂecting the deposition of subcutaneous fat in the
neck or fat surrounding the respiratory tract, and can help deter-
mine the degree of obesity, particularly upper body adiposity [6,7].
Recently, more and more studies indicate that NC is closely corre-
lated with glucolipid dysregulation, hyperinsulinemia, homeostasis
model assessment of insulin resistance (HOMA-IR) and other CVD
risk factors [8,9]. Stronger correlations of NC with such risk factors
were found more among women than men [9]. NC, visceral adipose
tissue (VAT) and body mass index (BMI) are all independent risk
factors for CVD [10].
In recent years, various studies have suggested that NC could be
used as a screening tool for overweight and obesity. However, at
present, more attention has been given to the correlation of NCwith
obesity and MS, while the connection between NC and NAFLD has
rarely been investigated. Hence, our study aimed to analyze the data
from subjects who had medical checkups in the medical checkup
center at the Changhai Hospital. The viability and value of NC, neck
circumference-height ratio (NHtR) and neck circumference-weight
ratio (NWtR) in predicting NAFLD were examined and discussed in
this study in order to provide clinicians and community health care
givers with a potential simple, effective and convenient index for
monitoring and prediction NAFLD.Materials and methods
Study population and basic information
This study involved a total of 2939 people who had a medical ex-
amination at the Changhai Hospital from the beginning of October
2012 to the end of November 2012. For all participants a detailed
medical history was taken and a physical examination, including
height, body weight, NC, waist circumference (WC) and hiphepatic and renal function, blood lipids, insulin, C-peptide, thyroid
function, etc. Abdominal ultrasounds were also performed. 2761
subjects with complete medical data were recruited after excluding
thosewho had excessive drinking problems, goiter, abnormal thyroid
function, hepatic and renal insufﬁciency, or past historyof stroke and/
or heart conditions. There were 967 subjects with NAFLD (Group B,
694 men/273 women) and 1171 subjects with other metabolic dis-
turbances (Group C, 703males/468 females) including hypertension,
diabetes or impaired glucose regulation, dyslipidemia, abdominal
obesity, overweight and obesity, hyperuricemia (HUA) and gout.
There were 623 healthy subjects (Group A, 183 men/440 women)
without one of the aforementioned metabolic disorders. All partici-
pants signed an informed consent form and the study protocol was
approved by the ethics committee at the Changhai Hospital.
Measurements
NC, WC and other anthropometric indexes, as well as blood
pressure, were measured by a designated person according to uni-
form methods. Subjects were required to fast, empty their bladder,
stand erect without shoes, breath normally and look straight ahead
withbotharmshangingnaturally. Theywerealso asked to relax their
neck when NC was measured, and to stand with their feet shoulder
distance apart whenWC and HCwere taken.WC and HCwere taken
to the nearest 1 mm, using a plastic tape measure at midpoint be-
tween the lower costal margin and the iliac crest, and at the point
yielding the maximum circumference over the gluteus maximus,
respectively. NC measurement was performed as previously
described [11]. NC was taken to the nearest 1 mm, measuring the
girth passing the superior margin of the seventh cervical vertebrae
and the inferior margin of the laryngeal prominence, which is at the
narrowest neck level. Height and bodyweight weremeasured using
an electronic scale (Kaiyuan electronic HW-600, Zhengzhou, China)
to the nearest 0.1 cm and 0.1 kg respectively.
Total cholesterol (TC) and TG were assayed enzymatically by a
RocheMODULARDPPautomatic biochemistry analyzer. High-density
lipoprotein cholesterol (HDL-C) and low-density lipoprotein choles-
terol (LDL-C) were assayed by immunoturbidimetry and ELISA,
respectively, using an autoanalyzer (Advia1650, Bayer Co., Germany).
Fasting blood glucose (FBG), alanine aminotransferase (ALT), aspar-
tate aminotransferase (AST), gamma-glutamyltransferase (g-GT),
serum uric acid (SUA), blood urea nitrogen (BUN), and serum creati-
nine (Scr) were measured by standard bioassay methods using an
automatic biochemistry analyzer. Hemoglobin A1c (HbA1c) was
measured by high performance liquid chromatography. The levels of
fasting insulin (FINS) and C-peptide were determined by radioim-
munoassay (Jiuding Biological Engineering Co., Tianjing, China). Free
triiodothyronine 3 (FT3), free thyroxine (FT4) and thyroid stimulating
hormone (TSH) were measured by electrochemiluminescence
immunoassay. HOMA-IR ¼ [FINS  FBG/22.5] was employed. The
quantitative insulin-sensitivity check index (QUICKI) ¼ [1/(log
FBG  log FINS)] was performed as described earlier [12]. Liver ul-
trasounds were performed by the same doctor using a 3.5-MHz
transabdominal probe and the GE LOGIQ E9 Agile color Doppler ul-
trasound systemmade in the USA.
Deﬁnition of cardio-metabolic risk factors
The diagnosis of NAFLD was based on the 2010-revised edition
of the Guidelines for the diagnosis and management of non-
alcoholic liver diseases by the Chinese National Consensus Work-
shop on NAFLD [13]. Diagnosis of the condition was made when
imaging ﬁndings of liver coincided with the diagnostic criteria of
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including excessive drinking, various types of viral hepatitis, etc.
NAFLD could be diagnosed when ﬁndings of liver ultrasonography
met certain criteria, including diffuse of liver tissue in the near ﬁeld
as compared to echogenicity of kidney and spleen, gradual atten-
uation of liver echogenicity in the far ﬁeld and obscure display of
intrahepatic vessels. NAFLD patients with elevated level of serum
ALT spanning more than half a year were further divided as NAFLD
with elevated ALT. Hypertension was diagnosed according to 2010
Chinese guidelines for the management of hypertension [14]. T2DM
and impaired glucose regulation were deﬁned according to the
WHO consultation in 1998 [15]. Dyslipidemia was diagnosed ac-
cording to Guidelines for management of adult dyslipidemia in
China [16]. Overweight and obesity were deﬁned in accordance
with The Guidelines for Prevention and Control of Overweight and
Obesity in Chinese adults [17]. Abdominal obesity was diagnosed if
WC was no less than 90 cm and 85 cm for men and women,
respectively. Participants without history of gout attack whose
fasting SUA exceeded 420 umol/L and 357 umol/L for men and
women respectively were diagnosed as HUA [18].
Statistical analysis
All data were input using Excel software and analyzed using
SPSS17.0 statistical software (SPSS Inc., Chicago, IL, USA). Means
between two groups were compared using Student’s t-test. Data
with skewed distribution including FINS, FCP and HOMA-IR were
converted to normal distribution after logarithmic transform prior
to correlation analysis. Sample rates were compared using c2 test.
Ranked data were analyzed by nonparametric test. Partial correla-
tion analysis was used and the correlation coefﬁcient was expressed
as r after adjusting confounding factors. The one-sided 1-a refer-
ence value range formula was <X þ uaS or >X  uaS. A P value
<0.05 was considered statistically signiﬁcant.Table 1
Comparison of clinical features and biochemical criterion between each group
Clinical indexes Group A Group B1
Case (n) (proportion) 623 (22.56%) 697 (25.24%)
M:F 183:440 463:234
Age (year)a 36.70  11.82 48.97  12.09
Weight (kg)a 56.21  7.31 72.73  10.50
Ma 62.49  7.06 76.89  8.96
Fa 53.59  5.62 64.43  8.17
BMI (kg/m2)a 20.92  1.84 26.29  2.83
NC (cm)a 32.60  2.37 37.21  3.06
Ma 35.34  1.90 38.75  2.17
Fa 31.46  1.42 34.17  2.15
NHtRa 0.20  0.01 0.22  0.02
Ma 0.21  0.01 0.23  0.01
Fa 0.19  0.01 0.22  0.01
NWtRb 0.59  0.05 0.52  0.05
M 0.57  0.05 0.51  0.05
F 0.59  0.05 0.54  0.05
WC (cm) Ma 77.78  6.63 93.44  7.50
Fa 71.40  5.52 85.47  7.74
WHRa 0.79  0.06 0.92  0.07
Ma 0.83  0.06 0.93  0.06
Fa 0.77  0.05 0.88  0.06
ALT (U/L)a 15.65  10.77 24.22  7.95
HbA1c (%)b 5.23  0.53 5.58  1.08
FINS (mIU/ml)a 18.68  8.43 26.51  13.59
FCP (ng/ml)a 2.55  0.93 3.79  1.43
HOMA-IRa 1.18  1.99 6.85  5.12
QUICKI 1.15  0.13 0.98  0.14
Group A, healthy subjects; Group B, NAFLD subjects; Group B1, subjects without elevated
disturbances.
a Differences are statistically signiﬁcant between each group in four groups (P < 0.05)
b Differences are no statistically signiﬁcant between group B1 and B2 (P > 0.05).Results
General characteristics and comparisons among metabolic proﬁles
According to the presence of NAFLD and other metabolic dis-
turbances, 2761 participants were divided into 3 groups (Table 1).
The prevalence of NAFLD without elevated ALT (Group B1) in men
and women was 29.30% and 19.81%, respectively and the preva-
lence of NAFLD with elevated ALT (Group B2) was 14.62% and
3.30% in men and women, respectively. The difference between
the incidence of both conditions was of statistical signiﬁcance
(Group B1: c2 ¼ 32.252, P < 0.001; Group B2: c2 ¼ 98.123,
P < 0.001). Mean values of NWtR among groups were in ascending
order of group B2, B1, C and A (P < 0.05). Mean values of NC, NHtR,
WC, body weight, WHR and BMI among groups were in ascending
order of group A, C, B1 and B2 in both sex (P < 0.001). The mean
value of NWtR was in descending order of group A, C and B
(P < 0.001) (Table 1).
Correlation analysis between anthropometric indices and IR in
NAFLD subjects
FINS and HOMA-IR were log10 transformed prior to the
following analysis. After adjusting for age, we found that NC, WC,
BMI, NHtR, NWtR, WHR and weight were correlated with FINS and
HOMA-IR in the NAFLD population, although the strength of cor-
relation differed in terms of sex. Furthermore, we found that WC in
men and NC in women had the strongest association with FINS and
HOMA-IR, respectively (Table 2). Two regression models
(Y ¼ 0.023x þ 0.6028 and Y ¼ 0.0267x þ 0.1296) were generated
based on the analysis of associations of NC with FINS and HOMA-IR
in women, respectively. Namely, an increment in NC of 1 cm was
associated with an increase of 1.87 mIU/ml and 1.43 in FINS and
HOMA, respectively.Group B2 Group C P-value
270 (9.78%) 1171 (42.41%)
231:39 703:468 <0.001
42.07  12.01 45.29  14.75 <0.001
79.56  11.71 65.44  10.16 <0.001
81.20  11.09 70.11  8.74 <0.001
69.91  10.65 58.40  7.84 <0.001
27.70  3.27 23.77  2.65 <0.001
38.94  2.62 35.33  3.03 <0.001
39.46  2.20 37.11  2.09 <0.001
35.86  2.78 32.65  2.12 <0.001
0.23  0.01 0.21  0.02 <0.001
0.23  0.01 0.22  0.01 <0.001
0.23  0.02 0.21  0.01 <0.001
0.50  0.06 0.54  0.06 <0.001
0.49  0.05 0.54  0.05 <0.001
0.53  0.05 0.57  0.06 <0.001
96.34  7.51 85.74  7.59 <0.001
90.14  9.47 78.38  7.74 <0.001
0.94  0.06 0.86  0.07 <0.001
0.95  0.05 0.88  0.06 <0.001
0.91  0.06 0.83  0.06 <0.001
66.26  30.16 21.38  12.19 <0.001
6.18  1.36 5.44  0.76 <0.001
33.7  19.17 20.92  9.31 <0.001
4.51  1.62 3.01  1.25 <0.001
9.17  7.50 5.05  3.07 <0.001
0.91  0.15 1.08  0.14 <0.001
ALT; Group B2, subjects with elevated ALT; Group C, subjects with other metabolic
.
Table 2
Correlational analysis between body measurements and FINS, HOMA-IR
Variables Lg (FINS) Lg (HOMA-IR)
Male Female Male Female
r-value P-value r-value P-value r-value P-value r-value P-value
NC (cm) 0.250 <0.001 0.345 <0.001 0.250 <0.001 0.339 <0.001
WC (cm) 0.351 <0.001 0.282 <0.001 0.325 <0.001 0.314 <0.001
BMI (kg/m2) 0.303 <0.001 0.318 <0.001 0.270 <0.001 0.298 <0.001
NHtR 0.166 <0.001 0.322 <0.001 0.165 <0.001 0.294 <0.001
NWtR 0.282 <0.001 0.121 0.073 0.243 <0.001 0.147 0.029
WHR 0.262 <0.001 0.207 0.002 0.260 <0.001 0.291 <0.001
Wt (kg) 0.338 <0.001 0.266 <0.001 0.307 <0.001 0.281 <0.001
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After adjusting for age, gender, hypertension, T2DM, hypercho-
lesterolemia, hypertriglyceridemia, low HDL-C levels, high LDL-C
levels, hyperuricemia, overweight, obesity, abdominal obesity and
so on, we used standardized NC, WC, BMI, NHtR, NWtR andWHR as
independent variables, and NAFLD as dependent variables respec-
tively to perform a Logistic regression analysis. Independent vari-
ables ﬁnally entering the model were NC, NHtR, NWtR and WHR.
After analyzing P value, we found that NHtR, NWtR and WHR are
the inﬂuencing factors of NAFLD. Comparing the odd ratio (OR)
presented in Table 3, NHtR was both the maximum risk factor for
the incidence of NAFLD and NAFLD without elevated ALT, while
both NHtR and WHR were risk factors for the incidence of NAFLD
with elevated ALT. In addition, both NC and NWtR were protective
factors for NAFLD, and NWtRwas a protective factor for NAFLDwith
or without elevated ALT.
Correlation analysis between NC and the incidence of NAFLD
Subjects were divided into 4 groups according to their gender-
speciﬁc NC quartiles (NC quartiles in men: <36 cm, 36e38 cm,
38e39 cm, 39 cm; NC quartiles in women: <31 cm, 31e32.5 cm,
32.5e34cm,34cm). Thoseparticipantswere furtherdichotomized
by the presence of abdominal obesity. Chi-square trend analysis
showed that the incidence of NAFLD was positively related to NC
whether they had abdominal obesity or not (P < 0.001) (Table 4).
Analysis of the incidence of NAFLD in different groups
Normal reference ranges of NC, NHtR and NWtR in healthy
controls were <38.51 cm, <0.23 and >0.49 in men and <33.80 cm,
<0.22 and >0.51 in women, respectively. Based on the establishedTable 3
Risk factors of NAFLD by logistic regression analysis
Risk
factors
B Wald P-
value
OR-
value
95% CI of OR
Upper
limit
Lower
limit
NAFLD
NC 0.369 3.748 0.053 0.691 0.476 1.005
NHtR 1.124 54.903 <0.001 3.078 2.286 4.144
NWtR 0.942 101.916 <0.001 0.390 0.325 0.468
WHR 0.647 52.313 <0.001 1.910 1.603 2.276
NAFLD without elevated ALT
NHtR 0.490 45.717 <0.001 1.632 1.416 1.882
NWtR 0.479 44.977 <0.001 0.619 0.538 0.712
WHR 0.315 13.526 <0.001 1.371 1.159 1.621
NAFLD with elevated ALT
NHtR 0.543 24.273 <0.001 1.721 1.387 2.136
NWtR 0.499 16.361 <0.001 0.607 0.477 0.773
WHR 0.549 15.993 <0.001 1.731 1.323 2.265gender-speciﬁc ranges, we divided the NAFLD subjects into two
groups, NC normal and abnormal. In both sexes, Chi-square trend
analysis showed that the incidence of NAFLD was positively related
to NC and NHtR, but inversely related to NWtR whether they had
abdominal obesity or not (P < 0.05) Table 5.
Determination of the diagnostic validity of NC and NHtR in NAFLD
by receiver operating characteristic (ROC) analysis
In males, the area under the curve (AUC) values for NC and NHtR
were 0.768 and 0.758, respectively. The best cut-off points for NC
and NHtR in men were 37.25 cm and 0.224, respectively (Youden
indices ¼ 0.386 and 0.377 for NC and NHtR). For males, the diag-
nostic value of NC in NAFLDwas better than that of NHtR (Figure 1).
As for women, AUC values for NC and NHtR were 0.798 and 0.806,
respectively. The best cut-off points for NC and NHtR in women
were 32.90 cm and 0.208, respectively (Youden indices ¼ 0.460 and
0.478 for NC and NHtR). For females, the diagnostic value of NHtR in
NAFLD was better than that of NC (Figure 1).
Discussion
NAFLD is a set of metabolic hepatic injuries caused by excess fat
deposition in the liver and its related conditions of hepatic cirrhosis
and liver cancer. It is closely related to metabolic abnormalities, as
well as obesity and T2DM, and has become the primary etiology of
the chronic liver disease. Our study demonstrated that NC in NAFLD
patients was signiﬁcantly wider than in patients with other meta-
bolic conditions or healthy controls. We also found that NAFLD
patients with elevated ALT had the largest NC among the NAFLD
population, which indicates that increased NC is a predictor of in-
ﬂammatory status in NAFLD sufferers and a risk factor for NAFLD
with elevated ALT.
The occurrence and development of NAFLD mainly comprises
resistance of insulin and leptin, overproduction of free radicals,
excessive accumulation of VAT and inﬂammation of adipose and
liver tissue. Studies in obese adult populations have shown that NC
signiﬁcantly correlated with levels of plasminogen activator in-
hibitor 1 (PAI-1), suggesting that NC could be a predictor of
enhanced inﬂammatory status and CVD risk in obese adults [19].Table 4
Comparison of NAFLD prevalence in different NC groups
NC Non-abdominal obesity Abdominal obesity
Cases (n) Prevalence (%) Cases (n) Prevalence (%)
<P25 70 9.41 (70/744) 18 51.43 (18/35)
P25eP50 122 19.03 (122/641) 110 58.20 (110/189)
P50eP75 96 29.81 (96/322) 137 62.56 (137/219)
>75 52 37.41 (52/139) 362 76.69 (362/472)
Total 340 18.42 (340/1846) 627 68.52 (627/915)
P, percentage.
Table 5
Analytical between NAFLD prevalence and body measurements
Body
measurements
Non-abdominal obesity Abdominal obesity
Cases
(n)
Prevalence (%) Cases
(n)
Prevalence (%)
NC (cm)
Male
<38.51 166 20.62 (166/805) 143 62.72 (143/228)
38.51 55 45.45 (55/121)** 330 77.46 (330/426)**
Female
<33.80 67 8.69 (67/771) 42 48.28 (42/87)
33.80 52 34.90 (52/149)** 112 64.37 (112/174)*
NHtR
Male
<0.23 163 20.3 (163/803) 215 63.8 (215/337)
0.23 57 47.5 (57/120)** 256 81.3 (256/315)**
Female
<0.22 90 10.5 (90/858) 76 53.5 (76/142)
0.22 28 49.1 (28/57)** 77 67.0 (77/115)*
NWtR
Male
>0.49 189 22.9 (189/829) 225 69.2 (225/325)
0.49 31 32.0 (31/97)* 246 75.2 (246/327)
Female
>0.51 100 11.9 (100/843) 84 53.8 (84/156)
0.51 18 25.0 (18/72)** 69 68.3 (69/101)*
vs normal values of same sex.
* P < 0.05, **P < 0.001.
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and 175 non-alcoholic steatohepatitis) which had serum immu-
noglobulins measured within 6 months of liver biopsy. They found
the serum IgA level was frequently elevated in patients with NAFLD
and was an independent predictor of advanced ﬁbrosis. As indi-
cated by previous studies, NAFLD is closely related to IR and is
intertwined with the pathogenesis of MS and T2DM. Clustering of
multiple metabolic disorders is commonly seen in NAFLD patients
[21e23], which was also observed in our study. NAFLD patients had
signiﬁcantly higher levels of TG, TC and LDL-C than thosewith other
metabolic disorders and healthy controls. Furthermore, the levels ofFigure 1. Receiver Operating Characteristic (ROC) curve of NC andTG, TC and LDL-C were positively correlated with the severity of
NAFLD in such patients (data unshown). It was indicated in recent
studies that NAFLD could occur in individuals with normal weight,
blood glucose and lipids. By following up those people, it was
revealed that they would suffer a markedly high incidence of dys-
glycemia, dyslipidemia and coronary artery disease [24]. Recently,
Hallsworth et al. [25] reported signiﬁcant changes in cardiac
structure and function are evident in adults with NAFLD in the
apparent absence of metabolic changes or overt cardiac disease.
Therefore, NAFLD could be amore accurate predictor for the odds of
developing DM and atherosclerosis than BMI and WC.
Currently, the predictive value of BMI, WC and WHR in deter-
mining the odds of developing DM, hypertension and dyslipidemia
and other metabolic disorders has been conﬁrmed [26]. However,
there are certain limitations in present simple anthropometric
measurements. For example, BMI is unable to reﬂect the content of
abdominal VAT precisely, and therefore it lacks accuracy in diag-
nosing abdominal obesity [27]. There are ethnic and sex variations
in WC and WHR. Indices like WC and body weight are easily
affected by external factors such as diet and exercise. Regardless of
gender, our study found that NC, NHtR,WC, bodyweight and BMI in
NAFLD patients were all signiﬁcantly higher than those without it.
Furthermore, these indices were positively correlated with the
severity of the NAFLD (all P < 0.001). WHR was signiﬁcantly higher
in males with NAFLD than in NAFLD-free subjects (P< 0.001), while
NWtR was signiﬁcantly lower in females with NAFLD than in
NAFLD-free subjects (P < 0.001). However, no statistically signiﬁ-
cant differences of WHR and NWtR were found between patients
with or without elevated ALT regardless of sex.
The liver is the main target site of insulin besides skeletal muscle
and adipose tissue. The inhibition of insulin during liver gluco-
genesis is enough to maintain normal levels of fasting plasma
glucose. As shown in a hyperinsulinemic-euglycemic clamp proce-
dure in conjunction with stable isotopically labeled glucose in-
fusions, the ability of insulin to inhibit hepatic glucose production is
impaired when excessive liver fat deposition or NAFLD occurs
[28,29]. Insulin resistance in the liver could lead tomild elevations of
plasma blood glucose thus stimulating insulin release. Our studyNHtR in distinguishing NAFLD or Non-NAFLD in different sex.
Y. Hu et al. / Journal of Clinical & Translational Endocrinology 1 (2014) 133e139138indicated that FINS in NAFLD patients was signiﬁcantly higher than
that in subjects with other metabolic disorders. Levels of FINS and
HOMA-IR positively correlated with the severity of NAFLD. After
adjusting for age, correlation analysis showed that among NAFLD
patients, WC had the greatest correlation with FINS and QUICKI
amongmenwhile NC had a similar correlation amongwomen. So, it
could be inferred that the ability of NC, WC and other anthropo-
metric indices to reﬂect abdominal obesity and insulin sensitivity
differs between sexes. Inwomen, NC is a better index thanWC,WHR
and BMI to predict NAFLD and to evaluate insulin levels and its
sensitivity in female NAFLD sufferers. We further analyzed the as-
sociation of NC with Log (FINS) and Log (HOMA-IR) in women, and
obtained two regression equations. According to the equations, FINS
and HOMA-IR increase by 1.87 mIU/ml and 1.43, respectivelywith an
increment of NC of 1 cm. It is corroborated in other studies that NC
has correlations with FBG, FINS and IR-related markers including
HOMA-IR [30,31], but to our knowledge, none of the reports covered
numerical relationships between NC and FINS and HOMA-IR.
Adipose tissue is an important component of the human body. It
comprises subcutaneous adipose tissue (SAT) and VAT [32,33]. If the
body fat is predominately SAT, the fat is mainly accumulated below
thewaist. On thecontrary, if the adipose tissue ismainly located in the
abdominal cavity or upper body, it ismainly VAT,which is also known
as visceral obesity. It is documented that great damage will arise if
adipose tissue inﬁltrates or covers visceral organs. Hence, excessive
VAT or abdominal obesity causes more impact on liver fat content
compared with overall fat depot, and also positively correlates with
the chance of developing NAFLD and MS. The present study showed
that regardless of gender and abdominal obesity, the odds of having
NAFLD positively relatedwith NC and NHtR, but negatively related to
NWtR, after we grouped the NAFLD subjects by NC quartiles (all
P < 0.05). So, it could be inferred that NC has a predictive value in
determining the chances of developing NAFLD. It was revealed by
Logistic regression analysis that among the anthropometric indices in
question, NC, NHtR, NWtR, and WHR correlated with NAFLD.
Furthermore, NHtR had the greatest positive relationship with the
odds of developing NAFLD without elevated ALT, while NWtR were
protective factors for NAFLD with or without elevated ALT. In our
study, thediagnosticvalidityofNCandNHtR forNAFLDwasexamined
using ROC analysis. It was shown that NC and NHtR could be used as
effective predictors for the risk of NAFLD. For the prediction of NAFLD,
NHtRhadbetter speciﬁcity and sensitivity inwomen than inmen and
NC also showed better speciﬁcity in women than in men. Our study
also inferred that fat deposits in the cervical region among women
were an overall better predictor than abdominal obesity.
In present study, objects were from physical examination center,
so they were only performed regular test excluded liver biopsy.
Although base on history and exits items, NAFLD can be diagnosed
[13], it would be better to evaluate the correlation between NC and
NAFLD process if liver biopsy or MRI could be performed. Liver bi-
opsy is the gold standard for diagnosis of NAFLD, but it is an invasive
examination, in the actual operation and ethical aspects, usually
can’t be used as the early detection and diagnosis of NAFLD and
non-alcohoic steatohepatitis on the basic of choice. Recently,
Angulo et al. [34] established a simple noninvasive scoring systems
which can help identify patients with NAFLD who are at increased
risk for liver-related complications or death. Currently we are also
investigating the relationship of NC to NAFLD. Among them the
important point is to identify liver fat deposit with magnetic
resonance spectroscopy, try to estimate a non-invasion test for
evaluating NAFLD.
Our study demonstrated that NC measurements could effec-
tively predict the risk of NAFLD, especially among women. It has
been proven that early detection and treatment of NAFLD and
amelioration of concomitant IR are conducive to the prevention andmanagement of a series of metabolic diseases. Based on the current
ﬁndings, measurement of WC should be highlighted among men
while NC should be used among women in health care practices of
prevention and management of NAFLD. Women with an
NC 34 cm should be recommended to have liver ultrasonography
every six months to ascertain the presence of liver steatosis. But the
results of this study require further validation.Acknowledgments
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